Veru Inc. (NASDAQ:VERU) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Call Transcript February 13, 2025 Veru Inc. beats earnings expectations. Reported EPS is $-0.06, ...
Psychedelic Breakthrough: Scientists Successfully Achieve Total Synthesis of Ibogaine
The discovery opens up opportunities to study the therapeutic properties of ibogaine and related compounds. Ibogaine, a ...
Hosted on MSN16h
Where Could The Avengers Be During The Events Of Thunderbolts*?
A recent Thunderbolts* trailer confirmed the Avengers won't help with the threat the eponymous team is facing, so where are ...
Connected To India12h
India Energy Week 2025: Puri spotlights biofuel, green hydrogen, and E&P reforms
The flagship energy event, now touted as the second biggest energy event in the world, commenced on February 11 and concluded ...
New findings on the power of enzymes could reshape biochemistry
Using a series of more than 1,000 X-ray snapshots of the shapeshifting of enzymes in action, researchers at Stanford ...
studyfinds on MSN1h
Eating yogurt may offer protection against hard-to-detect colon cancer
Can yogurt help combat colon cancer? Find out how Bifidobacterium in yogurt may offer protective effects against cancer.
The Daily Princetonian17h
New Humanities Institute explores outreach to community colleges, public schools
Two months after the Steering Committee met for the first time, members discuss their optimism for the Initiative, including ...
AFP16h
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...